Gary S Jacob - Net Worth and Insider Trading
Gary S Jacob Net Worth
The estimated net worth of Gary S Jacob is at least $141,774 dollars as of 2024-04-18. Gary S Jacob is the Director of Cardiff Oncology Inc and owns about 21,922 shares of Cardiff Oncology Inc (CRDF) stock worth over $95,251. Gary S Jacob is the Director of Hepion Pharmaceuticals Inc and owns about 12,059 shares of Hepion Pharmaceuticals Inc (HEPA) stock worth over $24,721. Gary S Jacob is also the CEO of OKYO Pharma Ltd and owns about 12,500 shares of OKYO Pharma Ltd (OKYO) stock worth over $18,000. Besides these, Gary S Jacob also holds Synergy Pharmaceuticals Inc (SGYPQ) , Virpax Pharmaceuticals Inc (VRPX) . Details can be seen in Gary S Jacob's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary S Jacob has not made any transactions after 2022-05-19 and currently still holds the listed stock(s).
Transaction Summary of Gary S Jacob
Gary S Jacob Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary S Jacob owns 5 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , Cardiff Oncology Inc (CRDF) , and Synergy Pharmaceuticals Inc (SGYPQ) among others .
Click here to see the complete history of Gary S Jacob’s form 4 insider trades.
Insider Ownership Summary of Gary S Jacob
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2020-12-01 | director & CEO and President |
| CRDF | Cardiff Oncology Inc | 2021-03-23 | director |
| SGYPQ | Synergy Pharmaceuticals Inc | 2018-06-15 | director & Executive Chairman |
| VRPX | Virpax Pharmaceuticals Inc | 2021-04-07 | director |
| OKYO | OKYO Pharma Ltd | 2022-05-19 | director & Chief Executive Officer |
Gary S Jacob Latest Holdings Summary
Gary S Jacob currently owns a total of 5 stocks. Among these stocks, Gary S Jacob owns 21,922 shares of Cardiff Oncology Inc (CRDF) as of March 23, 2021, with a value of $95,251 and a weighting of 67.19%. Gary S Jacob owns 12,059 shares of Hepion Pharmaceuticals Inc (HEPA) as of December 1, 2020, with a value of $24,721 and a weighting of 17.44%. Gary S Jacob also owns 12,500 shares of OKYO Pharma Ltd (OKYO) as of May 19, 2022, with a value of $18,000 and a weighting of 12.7%. The other 2 stocks Synergy Pharmaceuticals Inc (SGYPQ) , Virpax Pharmaceuticals Inc (VRPX) have a combined weighting of 2.68% among all his current holdings.
Latest Holdings of Gary S Jacob
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2021-03-23 | 21,922 | 4.35 | 95,251 |
| HEPA | Hepion Pharmaceuticals Inc | 2020-12-01 | 12,059 | 2.05 | 24,721 |
| OKYO | OKYO Pharma Ltd | 2022-05-19 | 12,500 | 1.44 | 18,000 |
| SGYPQ | Synergy Pharmaceuticals Inc | 2017-05-26 | 402,679 | 0.01 | 2,577 |
| VRPX | Virpax Pharmaceuticals Inc | 2021-02-17 | 350 | 3.50 | 1,225 |
Holding Weightings of Gary S Jacob
Gary S Jacob Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary S Jacob has made a total of 2 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 2,370 shares on March 23, 2021, which cost Gary S Jacob around $24,695.
According to the SEC Form 4 filings, Gary S Jacob has made a total of 1 transactions in Hepion Pharmaceuticals Inc (HEPA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Hepion Pharmaceuticals Inc is the acquisition of 12,000 shares on December 1, 2020, which cost Gary S Jacob around $19,920.
According to the SEC Form 4 filings, Gary S Jacob has made a total of 1 transactions in OKYO Pharma Ltd (OKYO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OKYO Pharma Ltd is the acquisition of 12,500 shares on May 19, 2022, which cost Gary S Jacob around $50,000.
More details on Gary S Jacob's insider transactions can be found in the Insider Trading History of Gary S Jacob table.Insider Trading History of Gary S Jacob
- 1
Gary S Jacob Trading Performance
GuruFocus tracks the stock performance after each of Gary S Jacob's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary S Jacob is 35.5%. GuruFocus also compares Gary S Jacob's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary S Jacob within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary S Jacob's insider trading performs compared to the benchmark.
Performance of Gary S Jacob
Average Relative Return
37.07%
Outperforming Transactions
17%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 12.27 | 35.5 | 183.95 | 37.07 | -43.78 | -31.74 |
| Relative Return to S&P 500(%) | 10.21 | 27.39 | 171.17 | 17.9 | -50.44 | -41.63 |
Gary S Jacob Ownership Network
Ownership Network List of Gary S Jacob
Ownership Network Relation of Gary S Jacob
Gary S Jacob Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Gary S Jacob is the director & CEO and President of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Scientific Officer Robert T Foster , Chief Financial Officer John T Cavan , and 10 percent owner Donald E Garlikov .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Gary S Jacob made no insider transaction in Hepion Pharmaceuticals Inc (HEPA). Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard , and a net purchase of 3,200 shares made by Robert T Foster .
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Gary S Jacob Mailing Address
Above is the net worth, insider trading, and ownership report for Gary S Jacob. Currently GuruFocus does not have mailing address information for Gary S Jacob.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
